Sign In
Buy BLCO
$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
Bausch + Lomb (BLCO) Lags Q4 Earnings Estimates
09:11am, Wednesday, 18'th Feb 2026
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.25 per share a year ago.
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
06:58am, Wednesday, 18'th Feb 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-qua
Ahead of Bausch + Lomb (BLCO) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:16am, Monday, 16'th Feb 2026
Beyond analysts' top-and-bottom-line estimates for Bausch + Lomb (BLCO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the qu
BLCO or DHR: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 09'th Feb 2026
Investors with an interest in Medical Services stocks have likely encountered both Bausch + Lomb (BLCO) and Danaher (DHR). But which of these two companies is the best option for those looking for und
BLCO vs. HQY: Which Stock Is the Better Value Option?
12:41pm, Friday, 23'rd Jan 2026
Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or HealthEquity (HQY). But which of these two stocks is more attractive to value investor
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
07:15am, Tuesday, 20'th Jan 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarte
Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
06:06pm, Monday, 12'th Jan 2026
Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
04:30pm, Friday, 02'nd Jan 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
07:30am, Tuesday, 23'rd Dec 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman
Bausch + Lomb Announces Two Board of Directors Appointments
04:30pm, Wednesday, 17'th Dec 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Eduardo C
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
04:10pm, Wednesday, 17'th Dec 2025
New York City-based DSC Meridian Capital sold 510,090 shares in Bausch + Lomb during the third quarter. The move marked a full exit from BLCO, with the fund reporting no shares held as of September 30
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
04:48pm, Friday, 12'th Dec 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12:43pm, Wednesday, 03'rd Dec 2025
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
BLCO Stock Still 16% Below IPO — Is Silver Point's $38.7 Million Bet a Turning Point?
11:10am, Wednesday, 03'rd Dec 2025
Connecticut-based Silver Point Capital added nearly 2.6 million BLCO shares in the third quarter, increasing its 13F portfolio by about $38.7 million. The transaction represents 2.8% of reportable U.S
